News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
Modernized Biotech Regulation Will Unleash…
The U.S. Department of Agriculture (USDA) released today a modernized, science-based regulatory system for plant biotechnology aimed at maintaining oversight while driving innovation. Now government and industry must do more to build an informed and…
BIO Appoints a Physician-Scientist as New…
Immunologist Michelle McMurry-Heath is Selected  for Her Global Leadership and Commitment to Innovation and Patients Former FDA Official Will Succeed Industry Leader Jim Greenwood  on June 1 as Leader of World’s Largest Biotechnology…
Dr. Moncef Slaoui “Excellent Choice” to Lead…
Following the announcement that Dr. Moncef Slaoui will lead the Trump Administration's "Operation Warp Speed" initiative, BIO’s President and CEO, Jim Greenwood, issued the following statement:  “Dr. Moncef Slaoui is an excellent choice…
Letters, Testimony, & Comments
An Inclusive and Impactful Approach to…
The U.S. government’s regulatory approach cannot exist in isolation. It should be supported by credible transparency measures. A proactive approach to transparency stands to build trust and foster an inclusive environment to address our most…
Congressional Letter to FDA Commissioner…
In recent years advances in animal genetics have provided significant breakthroughs that can help to address some of society's most difficult challenges. These technologies can treat and protect animals from illness; limit the transmission of…
Senate Letter to Administration to Reject RFS…
We urge you to direct the EPA to reject all calls to waive the RFS. The RFS is more important now than ever as farmers, the biofuel sector, and rural America struggle to remain operating amid the COVID-19 crisis.
Amicus Briefs
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
BIO Files Amicus Brief on Case Addressing…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Blog Posts
One-on-One-George-Scangos
May 21, 2020
Biotechnology companies, large and small, are working hard to more effectively treat and safely prevent the spread of COVID-19. For an episode of the I AM BIO Podcast, BIO President & CEO Jim Greenwood was joined by…
Beyond Imaagination
May 22, 2020
This is the fourth post in our series, Biotechnology: Beyond Imagination, which highlights the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Today we explore…
Beyond Imaagination
May 20, 2020
We highlight the technology and scientific advancements of BIO Digital participating companies and BIO member companies in our Biotechnology: Beyond Imagination series. Our next feature focuses on Sangamo Therapeutics…